Community Research and Development Information Service - CORDIS

Abstract

The report provides the comprehensive risk assessment of the substance sodium perborate (sodium perborate monohydrate and sodium perborate tetrahydrate). It has been prepared by Austria in the frame of Council Regulation (EEC) No. 793/93 on the evaluation and control of the risks of existing substances, following the principles for assessment of the risks to humans and the environment, laid down in Commission Regulation (EC) No. 1488/94. Part I - Environment. This part of the evaluation considers the emissions and the resulting exposure to the environment in all life cycle steps. Following the exposure assessment, the environmental risk characterisation for each protection goal in the aquatic, terrestrial and atmospheric compartment has been determined. The environmental risk assessment concludes that there is no concern for any compartment arising from the use of the substance. Part II - Human Health. This part of the evaluation considers the emissions and the resulting exposure to human populations in all life cycle steps. The scenarios for occupational exposure, consumer exposure and humans exposed via the environment have been examined and the possible risks have been identified. The human health risk assessment concludes that there is no concern for the endpoints acute toxicity, irritation, sensitisation, mutagenicity, carcinogenicity, and fertility for workers in production. No concern for any endpoints also applies to workers during formulation and contact to end products, as well as to consumers and humans exposed via the environment. For workers in the production of sodium perborate, there is concern for effects on the upper airways and for developmental effects after high inhalation exposure to sodium perborate dust. The conclusions of this report will lead to risk reduction measures to be proposed by the Commission's committee on risk reduction strategies set up in support of Council Regulation (EEC) N. 793/93.

Additional information

Authors: MUNN SJ, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);ASCHBERGER K, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);COSGROVE O, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);DE COEN W, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);LUND B-O, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);PAKALIN S, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);PAYA-PEREZ A, European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT);VEGRO S (Editors), European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (IT)
Bibliographic Reference: EUR 22873 EN (2007), various paging. Free of charge
Availability: Katalogue Number: LB-NA-22873-EN-C The PDF version can be downloaded from: http://bookshop.europa.eu
Record Number: 200819753 / Last updated on: 2008-05-05
Category: PUBLICATION
Original language: en
Available languages: en
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top